Sonoma Pharmaceuticals enters manufacturing supply agreement with Kenvue for Microcyn products in US

Sonoma Pharmaceuticals, Inc.

Agreement with Kenvue Brands LLC for US sale of Microcyn-based products, effective Oct 24, 2025 through March 2027.
Term includes two optional one-year renewals upon mutual written agreement.
Kenvue is not obligated to buy any minimum quantity; binding orders from 12-week forecast periods.
Most-favored-customer clause requires Sonoma to extend better pricing offered to comparable CPG customers to Kenvue.
Agreement is non-exclusive; Kenvue may manufacture or source similar products from third parties.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Sonoma Pharmaceuticals, Inc. entered into Manufacturing and Supply Agreement with Kenvue Brands LLC (effective 2025-10-24).

Action: entry
Agreement: supply
Counterparty: Kenvue Brands LLC
Effective: 2025-10-24

Exact text from the filing

On April 8, 2026, we entered into a Manufacturing and Supply Agreement with Kenvue Brands LLC for the sale of Microcyn ® technology-based products in the United States.

View on SEC.gov

Browse all material agreements →

Sonoma Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-26-002761

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.